General considerations on first-in-human dose estimation for anti-cancer drug clinical trials
YE Xuan
ZHANG Min
YAN Li-ping
YU Bing
ZHU Fei-peng
LIU Yi-bo
WANG Qing-li
WANG Hai-xue
Machine-generated Keywords：
Publication Date：2019-01-01
Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)
Pages：3( 2117-2119 )